Subtenon vs intravitreal triamcinolone injection in diabetic macular edema: A prospective study in chinese population
DOI:
https://doi.org/10.12669/pjms.304.4810Keywords:
Diabetic Retinopathy, Intravitreal, Macular Edema, Subtenon, Triamcinolone.Abstract
Objective: Purpose of this study was to validate that Subtenon (SB) Triamcinolone (TA) injection is an alternative to Intravitreal (IV) Triamcinolone (TA) injection for the treatment of diabetic macular edema (DME).
Methods: Forty eyes were selected having DME due to type 1 or type 2 diabetes. All the patients were treated with photocoagulation. IVTA was administered in one eye and SBTA in following eye of same patient. Improvement in visual acuity, macular edema and intraocular pressure was assessed before treatment and on 2nd, 4th, 8th and 12th week after treatment.
Results: After administration of IVTA, MVA was reduced from baseline value (0.805
Downloads
Published
2014-06-06
How to Cite
Luo, D., Zhu, B., Zheng, Z., Zhou, H., Sun, X., & Xu, X. (2014). Subtenon vs intravitreal triamcinolone injection in diabetic macular edema: A prospective study in chinese population. Pakistan Journal of Medical Sciences, 30(4). https://doi.org/10.12669/pjms.304.4810
Issue
Section
Original Articles





